It has been described that P-glycoprotein/ABCB1 is linked to worse survival prognosis [23,24,75], including leukemia, multiple myeloma, and hepatocellular carcinoma albeit with low patient numbers [76,77,78,79]. Here, ABCB1 is linked to hepatocellular carcinoma.